Syeda Fatima Shariq

Syeda Fatima Shariq

Auto-generated profile, based on publicly available information

Syeda Fatima Shariq

Medical College, Aga Khan University, Karachi, Pakistan

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2024 in World Neurosurgery
Verified
Journal Article
Closed access
MSMuhammad Shakir
Muhammad Shakir
SSSyeda Fatima Shariq
Syeda Fatima Shariq
HIHammad Atif Irshad
Hammad Atif Irshad
AKAly Hamza Khowaja
Aly Hamza Khowaja
ITIzza Tahir
Izza Tahir
SESyed Ather Enam
Syed Ather Enam

23 July 2024 in World Neurosurgery
Verified
Journal Article
Closed access
MSMuhammad Shakir
Muhammad Shakir
SSSyeda Fatima Shariq
Syeda Fatima Shariq
ITIzza Tahir
Izza Tahir
AKAly Hamza Khowaja
Aly Hamza Khowaja
HIHammad Atif Irshad
Hammad Atif Irshad
SESyed Ather Enam
Syed Ather Enam

21 November 2024 in World Neurosurgery
Verified
Journal Article
Closed access
MSMuhammad Shakir
Muhammad Shakir
AKAly Hamza Khowaja
Aly Hamza Khowaja
HIHammad Atif Irshad
Hammad Atif Irshad
ITIzza Tahir
Izza Tahir
SSSyeda Fatima Shariq
Syeda Fatima Shariq
SESyed Ather Enam
Syed Ather Enam

20 July 2024 in World Neurosurgery
Verified
Journal Article
Closed access
MSMuhammad Shakir
Muhammad Shakir
SSSyeda Fatima Shariq
Syeda Fatima Shariq
HIHammad Atif Irshad
Hammad Atif Irshad
AKAly Hamza Khowaja
Aly Hamza Khowaja
ITIzza Tahir
Izza Tahir
SESyed Ather Enam
Syed Ather Enam

10 July 2024 in Neurosurgery
Verified
Journal Article
Closed access
HIHammad Atif Irshad
Hammad Atif Irshad
SSSyeda Fatima Shariq
Syeda Fatima Shariq
MKMuhammad Ali Akbar Khan
Muhammad Ali Akbar Khan
TSTaha Shaikh
Taha Shaikh
WKWasila Gul Kakar
Wasila Gul Kakar
SESyed Ather Enam
Syed Ather Enam
BACKGROUND AND OBJECTIVES: Vague symptoms and a lack of pathognomonic features hinder the timely diagnosis of pediatric brain tumors (PBTs). However, patients in low- and middle-income countries (LMICs) must also bear the brunt of a multitude of additional factors contributing to diagnostic delays and subsequently affecting survival. Therefore, this study aims to assess these factors and quantify the durations associated with diagnostic delays for PBTs in LMICs. METHODS: A systematic review of extant literature regarding children from LMICs diagnosed with brain tumors was conducted. Articles published before June 2023 were identified using PubMed, Google Scholar, Scopus, Embase, Cumulative Index to Nursing and Allied Health Literature, and Web of Science. A meta-analysis was conducted using a random-effects model through R Statistical Software. Quality was assessed using the Newcastle Ottawa Scale. RESULTS: A total of 40 studies including 2483 patients with PBT from 21 LMICs were identified. Overall, nonspecific symptoms (62.5%) and socioeconomic status (45.0%) were the most frequently reported factors contributing to diagnostic delays. Potential sources of patient-associated delay included lack of parental awareness (45.0%) and financial constraints (42.5%). Factors contributing to health care system delays included misdiagnoses (42.5%) and improper referrals (32.5%). A pooled mean prediagnostic symptomatic interval was calculated to be 230.77 days (127.58-333.96), the patient-associated delay was 146.02 days (16.47-275.57), and the health care system delay was 225.05 days (−64.79 to 514.89). CONCLUSION: A multitude of factors contribute to diagnostic delays in LMICs. The disproportionate effect of these factors is demonstrated by the long interval between symptom onset and the definitive diagnosis of PBTs in LMICs, when compared with high-income countries. While evidence-based policy recommendations may improve the pace of diagnosis, policy makers will need to be cognizant of the unique challenges patients and health care systems face in LMICs.

5 July 2024 in Neurosurgery
Verified
Journal Article
Closed access
MSMuhammad Shakir
Muhammad Shakir
ITIzza Tahir
Izza Tahir
SSSyeda Fatima Shariq
Syeda Fatima Shariq
AKAly Hamza Khowaja
Aly Hamza Khowaja
HIHammad Atif Irshad
Hammad Atif Irshad
SESyed Ather Enam
Syed Ather Enam
BACKGROUND AND OBJECTIVES: Brain tumors have a poor prognosis and a high death rate. Sufficient aftercare is necessary to enhance patient results. But follow-up care provision is fraught with difficulties in low- and middle-income countries (LMICs), where a variety of variables can impede access to care. Therefore, our systematic review aimed to identify challenges to follow-up care for brain tumors and possible solutions in LMICs. METHODS: A thorough search of the literature was performed from the beginning until October 20, 2022, using Google Scholar, PubMed, Scopus, and CINAHL. Studies focusing on the aftercare of brain tumors in LMICs met the inclusion criteria. Two reviewers used the National Surgical, Obstetric, and Anesthesia Plan categories to identify themes, extract relevant data, and evaluate individual articles. After being discovered, these themes were arranged in Microsoft Excel to make reporting and comprehension simpler. RESULTS: A total of 27 studies were included in the review. Among the studies included, the most frequently cited barriers to follow-up care were financial constraints (54%), long-distance travel (42%), and a lack of awareness about the importance of follow-up care (25%). Other challenges included preference for traditional or alternative medications (4%) and high treatment costs (8%). Proposed strategies included implementing mobile clinics (20%), establishing a documentation system (13%), and educating patients about the importance of follow-up care (7%). CONCLUSION: In LMICs, several issues pertaining to personnel, infrastructure, service delivery, financing, information management, and governance impede the provision of follow-up treatment for patients with brain tumors. As established by the suggested techniques found in the literature, addressing these issues will necessitate concurrent action by stakeholders, legislators, health ministries, and government agencies.